News from NYU Langone Health
Newsday
Alec Kimmelman, MD, PhD, dean of NYU Grossman School of Medicine and CEO of NYU Langone Health, unveiled a multibillion-dollar plan for a 500-bed academic medical center in Melville—Long Island’s first new hospital since 1980. Kimmelman envisions a "state-of-the-art hospital of the future" that relocates the medical school to an expansive campus. The project aims to transform regional care, boost the economy, and secure the system’s legacy for the next century.
Also reporting was: , , , , , , , , , , , , , ,
6/03/2026
Newsday
Many residents are optimistic about the new academic medical center. While some still have questions, one local business owner said it will be “great for business” and Stacey I. Sikes, acting president and CEO of the Long Island Association, said it "will further establish our region as a center for innovation and advanced medicine." This will be the first new hospital on Long Island in nearly five decades.
6/03/2026
Newsday
The 2024 Melville Town Center Overlay District was the catalyst for the project. By focusing development on Maxess Road, Huntington officials created a walkable environment that Kimmelman says "dovetails perfectly" with staff housing needs. The article also includes comments from Huntington Town Supervisor Ed Smyth, who said: “You can't overstate the positive impacts this will have on Huntington and Suffolk County at large.”
6/03/2026
Becker's ASC Review
Christine Ren-Fielding, MD, division chief of Bariatric Surgery at NYU Langone Health and professor of surgery at NYU Grossman School of Medicine, is spearheading the use of magnetic compression technology, representing a major advancement in gastrointestinal surgery. By replacing traditional staples with self-forming magnets during gastric bypass procedures, she aims to reduce long-standing complications such as leaks, bleeding, and strictures. Dr. Ren-Fielding highlights that this innovation integrates seamlessly into existing workflows while potentially decreasing intraoperative time and hospital readmissions. She views this technology as a significant "paradigm" shift from 50-year-old methods, potentially paving the way for future non-invasive, endoscopic digestive connections.
6/03/2026
Bloomberg News
A new pancreatic cancer drug, daraxonrasib, doubled patient survival time in a late-stage trial, representing a paradigm shift for the disease. While the drug will become a new standard of care, Manuel Hidalgo Medina, MD, co-director of NYU Grossman School of Medicine's Gastrointestinal 鶹Ƶapp Center, noted that understanding its effectiveness across different genetic mutations is crucial for patient conversations and could influence whether some patients first consider other clinical trials.
Also reporting was: , , , ,
6/02/2026
UroToday
A paper co-authored by researchers including Sungmin Woo, MD, PhD, associate professor in the Department of Radiology at NYU Grossman School of Medicine, and Alberto Vargas, MD, vice chair of Oncologic Imaging and Strategy, and professor in the Department of Radiology at NYU Grossman School of Medicine, outlines future perspectives for the Vesical Imaging-Reporting and Data System (VI-RADS). Since its introduction, MRI using VI-RADS has become crucial for managing bladder cancer. The authors highlight areas for continued improvement, including the use of intravenous contrast media, quantitative metrics for muscle invasion assessment, enhancing image quality, and applying artificial intelligence to improve diagnostic performance.
6/02/2026
USA Today
A rising demand for protein is causing shortages and price increases for whey protein powder, a common supplement. While the trend of 'proteinmaxxing' grows, many Americans already consume more protein than needed. Priya Jaisinghani, MD, an endocrinologist and obesity medicine specialist at NYU Langone Medical Associates—Penn District and clinical assistant professor at NYU Grossman School of Medicine, cautions that excess protein may accelerate kidney function decline in individuals with chronic kidney disease. The article also notes that people using GLP-1 drugs might benefit from supplemental protein to counteract muscle loss from decreased appetite, despite the supply challenges manufacturers are facing.
Also reporting was: ,
6/02/2026
Becker's Spine Review
Several orthopedic and spine surgery leaders discussed the consequential decision of when not to operate, highlighting that patient welfare should always supersede financial incentives. Joseph Zuckerman, MD, chair of the Department of Orthopedic Surgery at NYU Langone Health and the Walter A.L. Thompson Professor of Orthopedic Surgery at NYU Grossman School of Medicine, commented that the foundation of medicine is the primacy of patient care. He stressed that professional ethics require surgeons to remain true to the indications for procedures they perform. According to Dr. Zuckerman, if a decision is based on the patient’s best interest, physicians fulfill their primary responsibility. Other experts also weighed in on the topic.
6/02/2026
Medscape
In a commentary, Adam Faye, MD, associate professor of medicine and population health and director of clinical research at the NYU IBD Center at NYU Langone Health, discusses the importance of early intervention in treating ulcerative colitis. He emphasizes that early treatment improves long-term outcomes, referencing a study showing biologic therapies are more effective when administered within one year of diagnosis. Faye outlines his approach to medication selection, which is primarily driven by disease severity. He also considers extraintestinal manifestations, comorbid conditions, and patient preferences when determining the most appropriate and efficacious therapy.
6/02/2026
Medical News Today
A phase 2b clinical trial shows that a personalized mRNA cancer vaccine from Moderna, used with Merck's Keytruda, significantly reduces the risk of melanoma spreading after surgery. The study's senior investigator, Janice Mehnert, MD, director of the melanoma and cutaneous medical oncology program and associate director of clinical research at Perlmutter 鶹Ƶapp Center, as well as professor in the Department of Medicine at NYU Grossman School of Medicine, explained the personalized approach. After five years, the combination therapy lowered the risk of distant metastasis by 59% compared to Keytruda alone. Overall survival was 92.2% in the combination group versus 71.3% in the Keytruda-only group. The findings were presented at the 2026 ASCO Annual Meeting.
Also reporting was: , , , , , , , , , , , , , , , , ,
6/02/2026
Blavity
The death of “30 Rock” actor Grizz Chapman from chronic kidney disease is highlighting the risks of the condition, its causes, and its disproportionate impact on the Black community. The article details the primary causes of kidney failure, such as diabetes and high blood pressure, and outlines key warning signs. Morgan Grams, MD, PhD, co-director of the Division of Precision Medicine and the Susan and Morris Mark Professor of Medicine at NYU Grossman School of Medicine, states that high blood pressure, obesity, heart disease, and diabetes all impact basic kidney function. The piece emphasizes proactive monitoring and managing chronic conditions to prevent irreversible organ damage.
Also reporting was:
6/02/2026
New York Post
Daniel Kaplan, MD, a sports orthopedic surgeon at the Joseph S. and Diane H. Steinberg Ambulatory Care Center—Cobble Hill, commented on Mitchell Robinson's recent surgery for a fractured hand. In the weekly 'Injury Report' segment, he explained that the procedure was likely the most effective option for the New York Knicks player. The discussion centered on the implications of the surgery as the team looks ahead to the 2026 NBA Finals, suggesting this course of action optimizes his recovery and future performance.
Also reporting was:
6/02/2026
Heavy
New York Yankees captain Aaron Judge is managing a bone bruise in his upper rib area, which could sideline him for an extended period. The injury has reportedly been affecting his swing and performance. Spencer Stein, MD, a sports orthopedic surgeon and clinical assistant professor of orthopedic surgery at NYU Grossman School of Medicine, explained that while the injury often responds to rest within one to two weeks, a more serious scenario like a stress fracture could extend the recovery timeline to eight to ten weeks.
Also reporting was:
6/02/2026
Entrepreneur
Prithvinath Garigapuram, founder of CARA Systems Inc., is developing clinical decision-support software for neurovascular conditions. The company is an NYU spinout that emerged from Garigapuram's graduate research at the university, where he collaborated with neurospecialists at NYU Langone on intracranial aneurysms and stroke-related disorders. CARA Systems, which was supported by programs including NYU Future Labs and NYU Leslie eLab, aims to provide clinicians with AI-assisted tools to make faster, more consistent, and patient-specific decisions. The platform turns clinical and imaging data into actionable insights at the point of care to improve patient outcomes.
6/02/2026
Clinical Correlations
An article by David Willett, a medical student at NYU Grossman School of Medicine, provides a historical overview of the pacemaker. The piece traces the device's evolution from Dr. Albert Hyman's 1932 invention to modern leadless, dual-chamber pacemakers from Medtronic and Abbott. Key developments highlighted include the first implantable device in 1958, the popularization of transvenous leads, the introduction of noninvasive programming, and the creation of implantable cardioverter-defibrillators (ICDs). The article concludes by noting that the future of pacemakers is focused on perfecting leadless technology for cardiac resynchronization therapy.
6/02/2026
